- Circulating Tumor Cell Core
Dear Core User,
Due to the current situation with COVID-19, per directives from Senior management at Partners and the Hospitals, this research core facilities will have a hiatus in their service offering. We will not be offering service till we are advised to resume operation.
Please stay safe in this challenging time and we look forward to working with you in the future.
Circulating Tumor Cell Core
The Circulating Tumor Cell Core Facility uses immunomagnetic technology developed by Veridex/Janssen Diagnostics, LLC (Raritan, NJ) to isolate rare tumor cells from whole blood. Isolated tumor cells can then be counted or used for downstream analysis.
Director: Alarice Lowe, M.D
Research Administrator Pathology Department: Mary LoGiudice-Croce
Grants Administrator Pathology Department: Mishell Alberto
Facilities and Equipment:
Brigham and Women's Hospital
Medical Research Building, 3rd Floor
75 Francis St.
Boston, MA 02115
CellTracks Analyzer II
To access the core please email Alarice Lowe, M.D : firstname.lastname@example.org
Departmental Web Link: